Vaxcyte, Inc. PCVX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s total current assets?
- Vaxcyte, Inc. (PCVX) reported total current assets of $1.81B in Q1 2026.
- How has Vaxcyte, Inc.'s total current assets changed year-over-year?
- Vaxcyte, Inc.'s total current assets increased by 5.6% year-over-year, from $1.72B to $1.81B.
- What is the long-term trend for Vaxcyte, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s total current assets has grown at a 33.1% compound annual growth rate (CAGR), from $389M to $1.63B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.